NRC Health Cash and Cash Equivalents, Fair Value Disclosure
NRC Health (NRC) had Cash and Cash Equivalents, Fair Value Disclosure of $36.06 million as of 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Notes
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2015-05-08
- 2015-03-31: Cash and Cash Equivalents, Fair Value Disclosure $36.06M.
- 2014-12-31: Cash and Cash Equivalents, Fair Value Disclosure $39.13M.
- 2014-09-30: Cash and Cash Equivalents, Fair Value Disclosure $37.14M.
- 2014-06-30: Cash and Cash Equivalents, Fair Value Disclosure $30.67M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2015-03-31 | $36.06M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $39.13M 10-Q · filed 2015-05-08 |
| 2014-09-30 | $37.14M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $30.67M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $25.24M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $21.24M 10-K · filed 2015-03-04 |
| 2013-09-30 | $18.24M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $10.01M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $8.89M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $7.49M 10-K · filed 2014-03-04 |
| 2012-09-30 | $14.71M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $11.15M 10-Q · filed 2012-08-10 |
| 2011-12-31 | $7.90M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |